TWiV 713: COVID-19 clinical update #47 with Dr. Daniel Griffin

In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Novavax vaccine phase 3 results (Novavax) J&J vaccine phase 3 results (J&J) COVID-19 and transmission in K-12 schools (MMWR) Lilly mAb therapy (NEJM) Regeneron mAb prophylaxis (Regeneron) Colchicine for COVID-19 (Cardiol Today) Letters read on TWiV 713 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]